Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 1, 2001, Pages 122-128

  Wilson, Stephanie H ^a   Simari, Robert D ^a   Best, Patricia J M ^a   Peterson, Tim E ^a   Lerman, Lilach O ^a   Aviram, Michael ^b   Nath, Karl A ^a   Holmes Jr , David R ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Endothelial NO synthase; Hypercholesterolemia; Nitric oxide; Vasorelaxation

Indexed keywords

NITRIC OXIDE SYNTHASE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ENZYME INHIBITION; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER; SWINE; TISSUE HOMOGENATE;

EID: 0035162842     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.1.122     Document Type: Article

References (39)

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
4. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
5. L-Arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules
6. Upregulation of endothelial nitric oxide synthase by HMGCoA reductase inhibitors
7. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
8. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia
9. Hypercholesterolemia increases endothelial superoxide anion production
10. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs
11. Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia
12. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine
13. Enzymatic determination of total serum cholesterol
14. The effect of basic fibroblastic growth factor on coronary vascular tone in experimental hypercholesterolemia in vivo and in vitro
15. Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia
16. Determination of plasma isoprostanes in normal pigs and in pigs with renal artery stenosis
17. Microsomal lipid peroxidation
18. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants
19. Renal oxidant injury and oxidant response induced by mercury
20. Endothelium-mediated coronary blood flow modulation in humans: Effect of age, atherosclerosis, hypercholesterolemia and hypertension
21. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia
22. Simvastatin, and HMGCoA reductase inhibitor, improves endothelial function within 1 month
23. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
24. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery
25. Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig
26. Effect of cholesterol lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease
27. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates
28. Pathophysiological consequences of atherosclerosis extent into the coronary microcirculation: Restoration of endothelium-dependent response by L-arginine
29. Coronary endothelial dysfunction in humans is associated with myocardial perfusion detects
30. Effect of cholesterol reduction on myocardial ischemia in patients with coronary artery disease
31. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment of patients with angina pectoris
32. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of the endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
33. Stroke protection by the 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
34. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo
35. Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia
36. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL
37. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans
38. Isoprostanes, potential markers of oxidant stress in atherothrombotic disease
39. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to human aortic endothelial cells